LCKLSL, an N-terminal hexapeptide, acts as a competitive inhibitor of annexin A2 (AnxA2), effectively preventing the binding of tissue plasminogen activator (tPA) to AnxA2 while also inhibiting the generation of plasmin. In addition, LCKLSL exhibits anti-angiogenic properties.
Molecular Weight:
675.89
CAS Number:
[533902-29-3]
Formula:
C30H57N7O8S
Target:
Annexin A
T40614
* VAT and and shipping costs not included. Errors and price changes excepted
